Swipe Left for the English Version

On May 11, Qiming Venture Partners' Healthcare Investment Team launched its 2026 PhD Summer Internship Program. If you're passionate about investing and entrepreneurship, apply now!

During this 8-10 week internship, you'll have the opportunity to work alongside the most innovative founders in biotech, medtech, AI healthcare, and other fields — and gain exclusive growth opportunities.

About Qiming Venture Partners

Qiming Venture Partners is a top-tier venture capital firm with a strong global reputation. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its founding, Qiming has focused on investing in outstanding companies at the early and growth stages in Technology and Healthcare.

Qiming Venture Partners has a professional investment team composed of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts, with extensive experience in building and operating businesses. Over the past 20 years, the high-growth healthcare companies Qiming has invested in have grown into leaders in their respective fields, developing synergistically within the Qiming ecosystem and creating greater value across more innovative areas.

Inclusion, drive, humility, and sincerity define our culture. Here, colleagues get along well, the work environment is friendly and harmonious, and teamwork is tight-knit. We hope to work with the next generation to find the best entrepreneurs, address unmet clinical needs, and create social good.

Join the Qiming Venture Partners PhD Summer Internship Program

What You'll Gain

• Comprehensive understanding and solid training in venture capital: Grounded in rigorous market research, you'll work closely with industry experts in healthcare innovation, participating in the full VC workflow — deal sourcing, due diligence, and deal execution — to build foundational skills and industry insight for early-stage healthcare investing;

• Immersive hands-on experience: Collaborate with our expert partners and top industry mentors, diving deep into investment practice. You'll have direct conversations with startup founders to identify market opportunities and assess deal value;

• A broad network across the healthcare industry: Engage face-to-face and work closely with influential founders of Qiming Venture Partners portfolio companies and industry leaders. While helping these companies, you'll accumulate expertise and build your own healthcare industry network;

• Real impact: Your research findings will be formally presented to our investment team, with professional feedback and targeted guidance — and may even directly influence our investment decisions;

• Pathways for continued growth: Outstanding performers during the internship may continue with remote part-time opportunities after the summer program; those with exceptional overall performance may be offered full-time positions.

What We Look For

• PhD students from top global universities

• Current PhD research areas including but not limited to: biomedical sciences, bioengineering, AI healthcare, Embodied Artificial Intelligence in healthcare, etc.

• Keen insight and judgment on frontier technologies, plus strong intellectual curiosity

• A strong entrepreneurial spirit

The summer internship requires full-time presence in Beijing or Shanghai, with flexibility for domestic travel during the program.

Apply Now

Experience industry growth together!

Please send your resume to HR@qimingvc.com by June 1, 2026. Include your name, school, major, and current PhD year in your resume.

---

Qiming Venture Partners Launches 2026 Healthcare PhD Summer Internship

PhD Summer Associate – Healthcare

Shanghai / Beijing

Biotech / Medtech / AI Healthcare

On May 11, the Healthcare Investment Team of Qiming Venture Partners launches our 2026 Healthcare PhD Summer Internship Program. Start Your Healthcare Investment Journey with us now!

Through this 8-10 weeks' internship program, you will gain hands-on experience to work with the most innovative founders across Biotech, Medtech, AI in Healthcare and more, and get growth opportunities.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Our professional investment team consists of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts. We have extensive experiences in building and operating a business.

Since our establishment, Qiming Venture Partners has earned extensive recognition from investors worldwide and has become an ideal VC firm for entrepreneurs, due to our exceptional investment performance. Qiming Venture Partners and our partners consistently rank among the leaders in the global venture capital industry across various prestigious lists.

Inclusion, staying hungry, humility, and sincerity are the core values of Qiming Venture Partners. We enjoy a friendly, harmonious, and cooperative working environment. We hope to work with young talents to find outstanding entrepreneurs, address clinical needs, and create social welfare.

Get a unique chance:

• A comprehensive exposure to the magic VC world: Through solid market research, you will work closely with our healthcare experts on deal sourcing, due diligence, and deal execution to shape your early-stage investment themes in healthcare.

• Learn from practice: Train with our expert partners and top industry mentors in the fundamentals of VC investment. You will talk directly to start-up founders, to identify market opportunities and assess real-world deal dynamics.

• Broad network in the healthcare industry: Directly communicate with influential CEOs of Qiming Venture Partners portfolio companies and industry KOLs. Help them, and in turn, help yourself to build your own industry network!

• Make a real impact: Formally present your findings to our VC investment team for feedback and mentorship. Your input may directly influence our investment decisions.

• Ongoing opportunities: Qualified interns will be offered a remote part-time internship after the summer internship. Outstanding candidates will have an opportunity for a full-time position after the program.

Qualifications:

• PhD candidate from a top-tier school in the US/UK.

• Current PhD fields include, but are not limited to: biomedical, bioengineering, AI in healthcare, robotics related to healthcare, etc.

• Sharp instinct for cutting-edge technologies.

• Strong entrepreneurial spirit.

• On-site in Beijing/Shanghai during the summer, and flexible to travel.

**Please submit your resume to HR@qimingvc.com before Jun. 1st 2026. Please include your name, university, major, and current PhD year in the resume.

往 期 回 顾

Qiming Honors | Qiming Venture Partners and Portfolio Companies Win Multiple Awards at the 9th Healthcare Investment Excellence Awards 2025 Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.15, 2026.4.28 Qiming Headlines | Qiming Venture Partners and Portfolio Companies Ranked TOP4 in ChinaVenture's 2025 Best VC Firms and Other Awards

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 companies have become recognized unicorns or super-unicorns.

Many of Qiming Venture Partners' portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 0800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), Hohobio, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.